Published in Eur J Clin Microbiol Infect Dis on January 31, 2011
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med (2011) 1.43
Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob Agents Chemother (2012) 1.24
Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J Clin Microbiol (2012) 1.05
Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients. J Clin Microbiol (2011) 1.00
Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates. Appl Environ Microbiol (2013) 0.99
Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains. Front Microbiol (2014) 0.95
The Microbiome in Cystic Fibrosis. Clin Chest Med (2015) 0.89
Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain. J Clin Microbiol (2013) 0.89
Isolation and characterization of numerous novel phages targeting diverse strains of the ubiquitous and opportunistic pathogen Achromobacter xylosoxidans. PLoS One (2014) 0.85
Draft Genome Sequence of Triclosan-Resistant Cystic Fibrosis Isolate Achromobacter xylosoxidans CF304. Genome Announc (2015) 0.84
Genetic Adaptation of Achromobacter sp. during Persistence in the Lungs of Cystic Fibrosis Patients. PLoS One (2015) 0.84
Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature. BMC Microbiol (2016) 0.80
Complete Genome Sequence of Achromobacter xylosoxidans MN001, a Cystic Fibrosis Airway Isolate. Genome Announc (2015) 0.79
Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol (2015) 0.79
Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis. Braz J Med Biol Res (2016) 0.78
Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients. Antimicrob Agents Chemother (2015) 0.77
Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis. J Cyst Fibros (2015) 0.76
Achromobacter buckle infection diagnosed by a 16S rDNA clone library analysis: a case report. BMC Ophthalmol (2014) 0.75
Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease. Am J Case Rep (2016) 0.75
Isolation of multiple drug-resistant enteric bacteria from feces of wild Western Lowland Gorilla (Gorilla gorilla gorilla) in Gabon. J Vet Med Sci (2015) 0.75
Hospital Acquired Pneumonia Due to Achromobacter spp. in a Geriatric Ward in China: Clinical Characteristic, Genome Variability, Biofilm Production, Antibiotic Resistance and Integron in Isolated Strains. Front Microbiol (2016) 0.75
Prevalence and Outcomes of Achromobacter species Infections in Adults with Cystic Fibrosis: A North American Cohort Study. J Clin Microbiol (2017) 0.75
A pan-genomic approach to understand the basis of host adaptation in Achromobacter. Genome Biol Evol (2017) 0.75
Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections. PLoS One (2016) 0.75
Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports. Respir Med Case Rep (2017) 0.75
Does a learned journal require regular re-vamping? Eur J Clin Microbiol Infect Dis (2016) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis (1998) 4.82
Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol (1988) 4.27
Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol (2002) 3.44
Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med (1996) 2.80
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med (2002) 2.41
Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis (2000) 2.17
Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect (2002) 2.01
Alcaligenes infection in cystic fibrosis. Pediatr Pulmonol (2002) 1.88
Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J Clin Microbiol (2002) 1.87
Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol (2001) 1.86
Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. Med Mycol (2008) 1.66
Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis. J Clin Microbiol (2002) 1.59
Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am J Respir Crit Care Med (2002) 1.46
Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses (2003) 1.45
Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis (2006) 1.39
Sphingobacterium respiratory tract infection in patients with cystic fibrosis. BMC Res Notes (2009) 1.32
Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis (1996) 1.31
Chronic airway colonization by Penicillium emersonii in a patient with cystic fibrosis. Med Mycol (1999) 1.28
Investigation of an outbreak of wound infections due to Alcaligenes xylosoxidans transmitted by chlorhexidine in a burns unit. Eur J Clin Microbiol Infect Dis (1998) 1.23
Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol (1999) 1.22
Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis (2004) 1.12
Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS (2008) 1.11
Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J Clin Microbiol (2005) 1.05
Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1997) 1.04
Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis. Eur J Clin Microbiol Infect Dis (1998) 1.02
Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit. Eur J Clin Microbiol Infect Dis (2005) 1.01
Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients. J Clin Microbiol (2010) 0.94
Chryseobacterium respiratory tract infections in patients with cystic fibrosis. J Infect (2007) 0.80
Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis. J Microbiol (2007) 0.79
Application of a computerised method to measure static pressure volume curve in acute respiratory distress syndrome. Intensive Care Med (2000) 1.95
Surface staining on the villus of lactase protein and lactase activity in adult-type hypolactasia. Gastroenterology (1993) 1.53
Immunobiological activities of Helicobacter pylori porins. Infect Immun (1994) 1.51
Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther (2004) 1.46
Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype characterization for patients with homozygote mutations. Clin Chem (1999) 1.44
[Effect of a surface-active substance on Euglena gracilis]. Riv Ist Sieroter Ital (1968) 1.39
Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Hosp Infect (2007) 1.23
Cystic fibrosis: when should high-resolution computed tomography of the chest Be obtained? Pediatrics (1998) 1.18
Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. Gastroenterology (1991) 1.17
Evaluation of IgA-mediated humoral immune response against the mycobacterial antigen P-90 in diagnosis of pulmonary tuberculosis. Chest (1997) 1.16
Epidemiology and a novel procedure for large scale analysis of CFTR rearrangements in classic and atypical CF patients: a multicentric Italian study. J Cyst Fibros (2008) 1.05
Self-perception and self-esteem of patients seeking cosmetic surgery. Aesthetic Plast Surg (2005) 1.05
Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther (2009) 1.03
FAS engagement drives apoptosis of enterocytes of coeliac patients. Gut (2001) 1.03
A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams. FEMS Microbiol Lett (1998) 1.01
DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? FEBS Lett (1997) 0.99
An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros (2009) 0.98
Toll-like receptor kinetics in septic shock patients: a preliminary study. Int J Immunopathol Pharmacol (2012) 0.98
IgA immune response against the mycobacterial antigen A60 in patients with active pulmonary tuberculosis. Respiration (1996) 0.97
Synergistic effects of cryolipolysis and shock waves for noninvasive body contouring. Aesthetic Plast Surg (2011) 0.97
Cirrhosis negatively affects the efficiency of serologic diagnosis of Helicobacter pylori infection. Ital J Gastroenterol (1997) 0.96
Immunobiological activities of mould products: functional impairment of human monocytes exposed to aflatoxin B1. Res Microbiol (1996) 0.95
Outer-membrane porins from gram-negative bacteria stimulate platelet-activating-factor biosynthesis by cultured human endothelial cells. Eur J Biochem (1993) 0.94
Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother (2009) 0.94
Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. Ann Hum Genet (2005) 0.94
Properties of Yersinia enterocolitica porins: interference with biological functions of phagocytes, nitric oxide production and selective cytokine release. Res Microbiol (1994) 0.93
Liver expression in cystic fibrosis could be modulated by genetic factors different from the cystic fibrosis transmembrane regulator genotype. Am J Med Genet (2001) 0.92
MALDI-TOF mass spectrometry and microsatellite markers to evaluate Candida parapsilosis transmission in neonatal intensive care units. Eur J Clin Microbiol Infect Dis (2012) 0.92
Severe cardiac anomalies in sibs with Larsen syndrome. J Med Genet (1983) 0.91
Delayed maturation of IgG avidity in congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis (2004) 0.90
Poland syndrome: description of an atypical variant. Aesthetic Plast Surg (2005) 0.90
Relative validity of multiple telephone versus face-to-face 24-hour dietary recalls. Ann Epidemiol (1994) 0.90
Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis. Thorax (1998) 0.90
Ultrasound measurement of gastric emptying time in patients with cystic fibrosis and effect of ranitidine on delayed gastric emptying. J Pediatr (1996) 0.89
Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. Cell Death Differ (2013) 0.89
Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes. Infect Immun (1997) 0.88
Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy. Clin Microbiol Infect (2005) 0.88
Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritis. Br J Rheumatol (1996) 0.87
Patchy expression of lactase protein in adult rabbit and rat intestine. Gastroenterology (1992) 0.87
Porin from Pseudomonas aeruginosa induces apoptosis in an epithelial cell line derived from rat seminal vesicles. Infect Immun (1999) 0.87
Proton NMR study of the state of water in fibrin gels, plasma, and blood clots. Magn Reson Med (1990) 0.87
Laparoscopy-guided biopsy in diagnosis of liver disorders in children. Liver (1997) 0.86
Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line. FEMS Microbiol Lett (2002) 0.86
Candida albicans identification: comparison among nine phenotypic systems and a multiplex PCR. J Prev Med Hyg (2010) 0.86
Individual perception of stress in the ICU. Eur J Anaesthesiol (2004) 0.85
Mosaic regulation of lactase in human adult-type hypolactasia. Gastroenterology (1994) 0.85
Incidence of antimicrobial-resistant ventilator associated pneumonia: an eighteen-month survey. Panminerva Med (2005) 0.84
Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution. Ann Hum Genet (1997) 0.83
Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness. Vaccine (1999) 0.83
Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides. Gastroenterology (1990) 0.83
Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis. Clin Otolaryngol Allied Sci (2003) 0.82
T serotyping and genomic profile of erythromycin-resistant or -sensitive Streptococcus pyogenes isolated in Campania Region, Italy. J Chemother (2005) 0.81
Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa. Pediatr Res (1988) 0.81
Porins and lipopolysaccharide stimulate platelet activating factor synthesis by human mesangial cells. Kidney Int (1992) 0.81
An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study. Dig Liver Dis (2009) 0.81
Laboratory survey of Chlamydia trachomatis ocular infections. Eur J Epidemiol (1990) 0.81
Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype. J Endocrinol Invest (2011) 0.81
Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine. Res Virol (1997) 0.81
Lung involvement, the delta F508 mutation and DNA haplotype analysis in cystic fibrosis. Hum Genet (1992) 0.81
ELISA method for evaluation of anti-A60 IgG in patients with pulmonary and extrapulmonary tuberculosis. New Microbiol (1994) 0.81
Secondary metabolites of Aspergillus exert immunobiological effects on human monocytes. Res Microbiol (1999) 0.80
[Italian Cystic Fibrosis Registry: 10 years of activity]. Epidemiol Prev (1999) 0.80
[The epidemiology of Burkholderia cepacia in cystic fibrosis patients: the initial results of a study including the genotypic typing of the strains isolated]. Ann Ig (2000) 0.80
Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, southern Italy): results of a pilot vaccination project. Res Virol (1999) 0.80
Defense mechanisms of IFN-gamma and LPS-primed murine microglia against Acanthamoeba castellanii infection. Int Immunopharmacol (2003) 0.79
Rat seminal vesicle protein SV-IV and its transglutaminase-synthesized polyaminated derivative SPD2-SV-IV induce cytokine release from human resting lymphocytes and monocytes in vitro. Cell Immunol (1996) 0.79
Serodiagnosis survey of tuberculosis by a new ELISA method. Eur J Epidemiol (1988) 0.79
Morphological method for the diagnosis of human adult type hypolactasia. Gut (1994) 0.79
Neutrophil function in rapidly progressive and adult periodontitis. Eur J Epidemiol (1992) 0.79
Performance characteristics of an enzyme-linked immunosorbent assay for determining salivary immunoglobulin G response to Helicobacter pylori. J Clin Microbiol (1999) 0.78
Mosaic differentiation of human villus enterocytes: patchy expression of blood group A antigen in A nonsecretors. Gastroenterology (1993) 0.78
Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study). J Pediatr Endocrinol Metab (2001) 0.78
Lipoteichoic acid and protein-A from Staphylococcus aureus stimulate release of hepatocyte growth factor (HGF) by human dermal fibroblasts. Arch Dermatol Res (1998) 0.78
Effects of ventilation in ventral decubitus position on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med (1997) 0.78
Micro magnetic resonance imaging of water uptake by glass ionomer cements. Dent Mater (1997) 0.78
Antibacterial activity of propolis and its active principles alone and in combination with macrolides, beta-lactams and fluoroquinolones against microorganisms responsible for respiratory infections. J Chemother (2006) 0.77
Clinical features of cystic fibrosis patients with rare genotypes. J Med Genet (1996) 0.77
Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy. J Chemother (2008) 0.77
Cisapride and cystic fibrosis. J Pediatr Gastroenterol Nutr (1989) 0.77
Histopathological features and modulation of type IV collagen expression induced by Pseudomonas aeruginosa lipopolysaccharide (LPS) and porins on mouse skin. Histol Histopathol (2001) 0.77
Nosocomial candida infections: epidemiology of candidaemia. J Prev Med Hyg (2006) 0.77
Effects of Cetyltrimethylammonium naproxenate on the adherence of Gardnerella vaginalis, Mobiluncus curtisii, and Lactobacillus acidophilus to vaginal epithelial cells. Sex Transm Dis (1995) 0.77
Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. Dig Liver Dis (2001) 0.77
Oral candidiasis: a comparison between conventional methods and multiplex polymerase chain reaction for species identification. Oral Microbiol Immunol (2009) 0.77
Percutaneous blind needle biopsy versus combined laparoscopic excisional and guided needle biopsy in the diagnosis of liver disorders in pediatric patients. Ital J Gastroenterol Hepatol (1997) 0.76
Chronic cryptogenic hepatitis in childhood is unrelated to hepatitis G virus. Pediatr Infect Dis J (1999) 0.76
Element concentrations and cataract: an experimental animal model. J Trace Elem Med Biol (2001) 0.76
Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure. J Med Genet (1996) 0.76
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Cell Death Differ (2016) 0.76
Brand new SPINK1 and CFTR mutations in a child with acute recurrent pancreatitis: a case report. Minerva Pediatr (2013) 0.76
Commonly used antibiotics induce expression of Hsp 27 and Hsp 60 and protect human lymphocytes from apoptosis. Int Immunopharmacol (2004) 0.76
Discrimination between neuropathy and myopathy by use of magnetic resonance imaging. Acta Neurol Scand (1993) 0.76
Survival to lipopolysaccharide, cytokine release and phagocyte functions in mice treated with different total parenteral nutrition regimens. Immunopharmacol Immunotoxicol (1995) 0.76
Typing of vancomycin-resistant Enterococcus faecium strains in a cohort of patients in an Italian intensive care Unit. Infection (2007) 0.76
Wildervanck's syndrome with bilateral subluxation of lens and facial paralysis. J Med Genet (1983) 0.76